skinny.

Latest / Inderes

Bioretec Q1'26: The beginning of the year offered positive signs

Bioretec's Q1 earnings positively surprised in terms of revenue and profit, particularly due to growth in the US and European markets. Bioretec's CEO, Sarah Hubar-Fisher, tells more about the first quarter in an interview with analyst Antti Siltanen.

Topics:

00:00 Introduction

00:15 Positive signs from the beginning of the year

01:41 Drivers behind the numbers

02:39 RemeOs sales

03:08 Orders affecting the comparison period

04:00 Taking RemeOs to China

04:37 Expanding the distributor network

05:35 Recruitment situation

06:30 Operational priorities for the rest of the year

Log in to save or queue this episode.

The skinny

The skinny isn't ready yet — notes appear once the transcript is processed.